Dilip Shanghvi

Title: Dilip Shanghvi: Innovator in Drug Delivery Technology

Introduction:

Dilip Shanghvi, a renowned inventor hailing from Mumbai, India, has made significant contributions to the field of drug delivery technology. As a key figure in the pharmaceutical industry and an influential researcher, Shanghvi has obtained four patents, two of which recently focus on abuse deterrent immediate release coated reservoir solid dosage forms and abuse deterrent immediate release biphasic matrix solid dosage forms. These inventions serve to improve drug administration, ensuring a more controlled release rate and enhancing patient safety. Shanghvi's invaluable work has been conducted under the prestigious SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED.

Dilip Shanghvi's Patented Innovations:

1. Abuse Deterrent Immediate Release Coated Reservoir Solid Dosage Form:

One of Dilip Shanghvi's notable patents is the abuse deterrent immediate release coated reservoir solid dosage form. Designed to release drugs at a desired rate for quick action when consumed in prescribed units, the innovative formulation exhibits a reduced release rate if more than the prescribed number of units are administered. This technology aims to address concerns related to drug abuse and misuse, providing an effective solution for controlling drug release patterns.

2. Abuse Deterrent Immediate Release Biphasic Matrix Solid Dosage Form:

Shanghvi's second recent patent revolves around abuse deterrent immediate release biphasic matrix solid dosage forms. Similar to the aforementioned invention, this technology ensures that drugs are delivered at the desired rate for prompt onset when consumed in recommended units. However, the release rate is reduced if the administered dosage exceeds the prescribed quantity. By mitigating the risks associated with improper drug usage, this innovation promotes safer medication practices for patients.

Shanghvi's Affiliation with SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED:

Dilip Shanghvi's groundbreaking inventions have been developed in collaboration with SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED, a prominent pharmaceutical research organization. Working under this esteemed company, Shanghvi has been able to combine his extensive industry knowledge with cutting-edge research resources, spearheading advancements in drug delivery technology.

Collaborators and Peers:

Within the research and development team at SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED, Dilip Shanghvi collaborates with notable individuals, including Nitin Dharmadhikari and Yashoraj Zala. These talented professionals contribute their expertise, collectively working towards the creation of innovative drug delivery systems and formulations for the benefit of patients worldwide.

Conclusion:

Dilip Shanghvi, an exemplary inventor and researcher specializing in drug delivery technology, has achieved significant breakthroughs in his field. His patented inventions, focusing on abuse deterrent immediate release coated reservoir solid dosage forms and abuse deterrent immediate release biphasic matrix solid dosage forms, showcase his commitment to ensuring the safe and controlled administration of medications. As an integral member of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED, Shanghvi continues to revolutionize drug delivery systems, contributing to advancements in the pharmaceutical industry and improving patient outcomes.